Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank75
3Y CAGR+24.8%
5Y CAGR-11.3%
Year-over-Year Change
Research and development spending
3Y CAGR
+24.8%/yr
vs -8.2%/yr prior
5Y CAGR
-11.3%/yr
Recent acceleration
Acceleration
+33.0pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.76M | +138.6% |
| 2024 | $3.25M | -2.0% |
| 2023 | $3.32M | -16.9% |
| 2022 | $4.00M | -35.9% |
| 2021 | $6.24M | -55.8% |
| 2020 | $14.10M | +22.1% |
| 2019 | $11.55M | +105.3% |
| 2018 | $5.63M | +43.2% |
| 2017 | $3.93M | - |